Antimycin A induces death of the human pulmonary fibroblast cells via ROS increase and GSH depletion

International Journal of Oncology

Volumn 48, Issue 2, 2016, Pages 813-820

  Park, Woo Hyun ^a   You, Bo Ra ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Antimycin A; Cell death; Glutathione; Human pulmonary fibroblast; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTIMYCIN A1; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CASPASE 3; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT; CASPASE INHIBITOR; GROWTH INHIBITOR;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; DNA CONTENT; FIBROBLAST; G1 PHASE CELL CYCLE CHECKPOINT; GLUTATHIONE METABOLISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUNG ALVEOLUS CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; CELL CYCLE G1 PHASE; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; LUNG; METABOLISM; OXIDATIVE STRESS;

ACETYLCYSTEINE; ANTIMYCIN A; ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; CASPASE INHIBITORS; CELL DEATH; CELL LINE; CELL PROLIFERATION; FIBROBLASTS; G1 PHASE; GLUTATHIONE; GROWTH INHIBITORS; HUMANS; LUNG; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84956898522     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3276     Document Type: Article

References (33)

1. Zorov DB, Juhaszova M and Sollott SJ: Mitochondrial ROS-induced ROS release: An update and review. Biochim Biophys Acta 1757: 509-517, 2006.
2. Zelko IN, Mariani TJ and Folz RJ: Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33: 337-349, 2002.
3. Wilcox CS: Reactive oxygen species: Roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
4. Marks PA: Thioredoxin in cancer-role of histone deacetylase inhibitors. Semin Cancer Biol 16: 436-443, 2006.
5. Alexandre A and Lehninger AL: Bypasses of the antimycin a block of mitochondrial electron transport in relation to ubisemiquinone function. Biochim Biophys Acta 767: 120-129, 1984.
6. Campo ML, Kinnally KW and Tedeschi H: The effect of antimycin A on mouse liver inner mitochondrial membrane channel activity. J Biol Chem 267: 8123-8127, 1992.
7. Balaban RS, Nemoto S and Finkel T: Mitochondria, oxidants, and aging. Cell 120: 483-495, 2005.
8. Panduri V, Weitzman SA, Chandel NS and Kamp DW: Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis. Am J Physiol Lung Cell Mol Physiol 286: L1220-L1227, 2004.
9. Petronilli V, Penzo D, Scorrano L, Bernardi P and Di Lisa F: The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 276: 12030-12034, 2001.
10. Pastorino JG, Tafani M, Rothman RJ, Marcinkeviciute A, Hoek JB and Farber JL: Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore. J Biol Chem 274: 31734-31739, 1999.
11. Park WH, Han YW, Kim SH and Kim SZ: An ROS generator, antimycin A, inhibits the growth of HeLa cells via apoptosis. J Cell Biochem 102: 98-109, 2007.
12. Park WH, Han YW, Kim SW, Kim SH, Cho KW and Kim SZ: Antimycin A induces apoptosis in As4.1 juxtaglomerular cells. Cancer Lett 251: 68-77, 2007.
13. K ing MA: Antimycin A-induced killing of HL-60 cells: Apoptosis initiated from within mitochondria does not necessarily proceed via caspase 9. Cytometry A 63: 69-76, 2005.
14. Guha G, Mandal T, Rajkumar V and Ashok Kumar R: Antimycin A-induced mitochondrial apoptotic cascade is mitigated by phenolic constituents of Phyllanthus amarus aqueous extract in Hep3B cells. Food Chem Toxicol 48: 3449-3457, 2010.
15. Y ou BR and Park WH: The effects of antimycin A on endothelial cells in cell death, reactive oxygen species and GSH levels. Toxicol In Vitro 24: 1111-1118, 2010.
16. Han YH and Park WH: Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis. Lung Cancer 65: 150-160, 2009.
17. Han YH, Kim SH, Kim SZ and Park WH: Antimycin A as a mitochondrial electron transport inhibitor prevents the growth of human lung cancer A549 cells. Oncol Rep 20: 689-693, 2008.
18. Han YH and Park WH: Tiron, a ROS scavenger, protects human lung cancer Calu-6 cells against antimycin A-induced cell death. Oncol Rep 21: 253-261, 2009.
19. Han YH, Kim SZ, Kim SH and Park WH: Pyrogallol inhibits the growth of lung cancer Calu-6 cells via caspase-dependent apoptosis. Chem Biol Interact 177: 107-114, 2009.
20. Y ou BR and Park WH: Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol In Vitro 24: 1356-1362, 2010.
21. Y ou BR, Kim SH and Park WH: Reactive oxygen species, glutathione, and thioredoxin influence suberoyl bishydroxamic acid-induced apoptosis in A549 lung cancer cells. Tumour Biol 36: 3429-3439, 2015
22. You BR, Shin HR, Han BR and Park WH: PX-12 induces apoptosis in Calu-6 cells in an oxidative stress-dependent manner. Tumour Biol 36: 2087-2095, 2015.
23. Jia L, Allen PD, Macey MG, Grahn MF, Newland AC and Kelsey SM: Mitochondrial electron transport chain activity, but not ATP synthesis, is required for drug-induced apoptosis in human leukaemic cells: A possible novel mechanism of regulating drug resistance. Br J Haematol 98: 686-698, 1997.
24. Han YH, Kim SH, Kim SZ and Park WH: Antimycin A as a mitochondria damage agent induces an S phase arrest of the cell cycle in HeLa cells. Life Sci 83: 346-355, 2008.
25. Han YW, Kim SZ, Kim SH and Park WH: The changes of intracellular H2O2 are an important factor maintaining mitochondria membrane potential of antimycin A-treated As4.1 juxtaglomerular cells. Biochem Pharmacol 73: 863-872, 2007.
26. Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM and Powis G: Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res 56: 5765-5770, 1996.
27. K im SJ, Miyoshi Y, Taguchi T, Tamaki Y, Nakamura H, Yodoi J, Kato K and Noguchi S: High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin Cancer Res 11: 8425-8430, 2005.
28. Poljsak B and Raspor P: The antioxidant and pro-oxidant activity of vitamin C and trolox in vitro: A comparative study. J Appl Toxicol 28: 183-188, 2008.
29. Halliwell B: Vitamin C: Antioxidant or pro-oxidant in vivo? Free Radic Res 25: 439-454, 1996.
30. Estrela JM, Ortega A and Obrador E: Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43: 143-181, 2006.
31. Higuchi Y: Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med 8: 455-464, 2004.
32. Han YH and Park WH: The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione. Oncol Rep 22: 385-391, 2009.
33. Park WH and You BR: Enhancement of gallic acid-induced human pulmonary fibroblast cell death by N-acetyl cysteine and L-buthionine sulfoximine. Hum Exp Toxicol 30: 992-999, 2011.